OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) passed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $5.41 and traded as low as $5.31. OneMedNet shares last traded at $5.37, with a volume of 12,165 shares traded.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, OneMedNet presently has an average rating of “Sell”.
Get Our Latest Stock Analysis on ONMD
OneMedNet Price Performance
The stock’s fifty day moving average price is $5.41 and its 200 day moving average price is $7.02. The stock has a market capitalization of $31.84 million, a P/E ratio of -3.36 and a beta of 1.25.
Insider Buying and Selling at OneMedNet
In related news, insider Jeffrey Yu bought 45,126 shares of OneMedNet stock in a transaction dated Friday, October 9th. The shares were acquired at an average cost of $5.54 per share, with a total value of $249,998.04. Following the completion of the transaction, the insider owned 896,840 shares in the company, valued at $4,968,493.60. The trade was a 5.30% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas Kosasa bought 129,758 shares of OneMedNet stock in a transaction dated Wednesday, October 7th. The shares were bought at an average cost of $5.78 per share, for a total transaction of $750,001.24. Following the completion of the transaction, the director owned 1,983,573 shares of the company’s stock, valued at approximately $11,465,051.94. This trade represents a 7.00% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders purchased 189,169 shares of company stock valued at $1,089,995 and sold 15,167 shares valued at $103,042. 50.20% of the stock is owned by corporate insiders.
About OneMedNet
OneMedNet Corporation (NASDAQ: ONMD) is a healthcare technology company focused on improving the access, exchange and use of medical imaging data. Its platform is designed to connect healthcare organizations, researchers, life sciences companies and other authorized users with clinical imaging datasets while supporting data privacy, security and governance requirements. OneMedNet’s technology uses a decentralized approach in which medical data can remain with the organization that originally collected it, rather than being transferred to a central repository.
Recommended Stories
- Five stocks we like better than OneMedNet
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
